10-K

Company

Hepion Pharmaceuticals, Inc.

Filed

April 10, 2023

Period of Report

December 31, 2022

Accession Number

0001583771-23-000003

A 10-K is a company's comprehensive annual report, required by the SEC. It includes audited financial statements, a description of the business, risk factors, and management's discussion of results. Learn more about 10-K filings →